SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094747
Filing Date
2024-08-09
Accepted
2024-08-09 16:06:00
Documents
51
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q maia-20240630.htm   iXBRL 10-Q 1618421
2 EX-31.1 maia-ex31_1.htm EX-31.1 17225
3 EX-31.2 maia-ex31_2.htm EX-31.2 17750
4 EX-32.1 maia-ex32_1.htm EX-32.1 9673
5 EX-32.2 maia-ex32_2.htm EX-32.2 10855
  Complete submission text file 0000950170-24-094747.txt   6571390

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT maia-20240630.xsd EX-101.SCH 943570
53 EXTRACTED XBRL INSTANCE DOCUMENT maia-20240630_htm.xml XML 1000226
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41455 | Film No.: 241192593
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)